Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 16366

Federal Way, WA 98003

Study Summary:

MK-3102 is being developed as a once-weekly treatment for type 2 diabetes mellitus (T2DM), a condition wherein the patient's blood sugar levels are abnormally high and the body cannot produce enough insulin. This study will test MK-3102 in subjects with T2DM with poor blood sugar control who have either moderate or severe long term kidney related diseases or who are on dialysis because kidneys have stopped functioning.

Qualified Participants Must:

• Be 30 years of age or older
• Have type 2 diabetes mellitus
• Not be pregnant, breastfeeding or unwilling to use birth control
• Not have participated in a study with an experimental drug or device within the previous 12 weeks
• Not have had an allergic reaction or bad experience using glipizide or insulin glargine

Qualified Participants May Receive:

$50 per completed study visit to reimburse for time and inconvenience related to study visits.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.